tiprankstipranks
Advertisement
Advertisement

EXEL Stock Latest News

BMO starts Exelixis at Market Perform into patent cliff
The FlyBMO starts Exelixis at Market Perform into patent cliff
4d ago
EXEL
Exelixis initiated with a Market Perform at BMO Capital
PremiumThe Fly
Exelixis initiated with a Market Perform at BMO Capital
4d ago
EXEL
Exelixis Earnings Call: Cabo Strength, Zanza Awaited
PremiumCompany Announcements
Exelixis Earnings Call: Cabo Strength, Zanza Awaited
15d ago
EXEL
Leerink downgrades Exelixis to Market Perform following Q2 results
PremiumThe Fly
Leerink downgrades Exelixis to Market Perform following Q2 results
17d ago
EXEL
Exelixis downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Exelixis downgraded to Market Perform from Outperform at Leerink
17d ago
EXEL
Exelixis Targets Residual Colorectal Cancer With New Phase 3 Trial
PremiumCompany AnnouncementsExelixis Targets Residual Colorectal Cancer With New Phase 3 Trial
17d ago
EXEL
Exelixis price target raised to $51 from $47 at Stifel
Premium
The Fly
Exelixis price target raised to $51 from $47 at Stifel
17d ago
EXEL
Exelixis price target lowered to $52 from $56 at Truist
Premium
The Fly
Exelixis price target lowered to $52 from $56 at Truist
17d ago
EXEL
Exelixis: Buy Rating Reaffirmed on Cabozantinib Resilience, Cost Discipline and Zanzalintinib Upside Despite Near-Term NET Guidance Cut
PremiumRatings
Exelixis: Buy Rating Reaffirmed on Cabozantinib Resilience, Cost Discipline and Zanzalintinib Upside Despite Near-Term NET Guidance Cut
17d ago
EXEL
Exelixis reports Q2 non-GAAP EPS 91, consensus 86c
PremiumThe Fly
Exelixis reports Q2 non-GAAP EPS 91, consensus 86c
17d ago
EXEL
Exelixis lowers FY26 revenue outlook to $2.5B-$2.55B from $2.525B-$2.625B
PremiumThe Fly
Exelixis lowers FY26 revenue outlook to $2.5B-$2.55B from $2.525B-$2.625B
17d ago
EXEL
EXEL Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EXEL Earnings this Week: How Will it Perform?
20d ago
EXEL
Exelixis price target raised to $53 from $50 at Morgan Stanley
PremiumThe FlyExelixis price target raised to $53 from $50 at Morgan Stanley
1M ago
EXEL
Exelixis price target raised to $49 from $45 at Barclays
Premium
The Fly
Exelixis price target raised to $49 from $45 at Barclays
1M ago
EXEL
Exelixis price target raised to $49 from $40 at Wells Fargo
Premium
The Fly
Exelixis price target raised to $49 from $40 at Wells Fargo
1M ago
EXEL
Citizens healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens healthcare analysts hold an analyst/industry conference call
2M ago
CTMX
EXEL
Exelixis price target raised to $56 from $54 at Truist
PremiumThe Fly
Exelixis price target raised to $56 from $54 at Truist
2M ago
EXEL
Exelixis price target raised to $46 from $43 at RBC Capital
PremiumThe Fly
Exelixis price target raised to $46 from $43 at RBC Capital
2M ago
EXEL
Exelixis price target raised to $52 from $43 at UBS
PremiumThe Fly
Exelixis price target raised to $52 from $43 at UBS
2M ago
EXEL
Apollo, Exelixis, Devon, Qualcomm, Oklo Trending With Analysts
PremiumWeekend UpdatesApollo, Exelixis, Devon, Qualcomm, Oklo Trending With Analysts
2M ago
ARI
DVN
Qualcomm upgrade, Intel initiation among today’s top calls on Wall Street
Premium
The Fly
Qualcomm upgrade, Intel initiation among today’s top calls on Wall Street
2M ago
MU
KDP
Exelixis assumed with Hold from Buy at Truist
Premium
The Fly
Exelixis assumed with Hold from Buy at Truist
2M ago
EXEL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >